
AnPac Bio-Medical Science Co., Ltd. ANPC
Geschäftsbericht 2022
hinzugefügt 27.12.2025
AnPac Bio-Medical Science Co., Ltd. DIO 2011-2025 | ANPC
DIO Jährlich AnPac Bio-Medical Science Co., Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 34.5 | 25.5 | 15 | 11.3 | 1.99 | - | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 34.5 | 1.99 | 17.7 |
DIO anderer Aktien in der Pharmaeinzelhändler
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aclaris Therapeutics
ACRS
|
42.1 | $ 3.02 | -0.5 % | $ 233 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
12 | $ 1.11 | -2.62 % | $ 6.05 M | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 12.42 | 0.57 % | $ 818 M | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
132 | $ 26.96 | -0.59 % | $ 1.31 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
247 | $ 9.53 | -0.21 % | $ 140 M | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M | ||
|
Cellectis S.A.
CLLS
|
23.3 | $ 4.93 | 3.79 % | $ 116 M | ||
|
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | ||
|
Axon Enterprise
AXON
|
116 | $ 581.87 | -0.34 % | $ 44.1 B | ||
|
Aytu BioScience
AYTU
|
209 | $ 2.55 | 4.08 % | $ 16 M | ||
|
AstraZeneca PLC
AZN
|
206 | $ 92.76 | -0.15 % | $ 96.9 B | ||
|
ChromaDex Corporation
CDXC
|
114 | - | -0.88 % | $ 598 M | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
CorMedix
CRMD
|
180 | $ 12.74 | 1.66 % | $ 649 M |